Avid Bioservices Inc (CDMO)

[entdoc]

"strong hands" biopharm? Poker, huh. Who blinks,and who dies of cancer tomorrow, next week, next year. A promising new anti-cancer drug stalled inside the red zone...after it scored a touchdown which was called back exactly one year ago. No harm, no foul. Not much. My retirement. Someone else's disease. Why the delay? Shamefully simple. Money. Not split to everyone's satisfaction. However, The genius of true invention is durability and sensibility. Anti-PS medical science is proving to have both. Witness the marked increased interest in that sector in the scientific liteature. Cheers to you all for a great weekend! Thanks for the unending entertainment and enlightenment, worthwhile diversion on our road to fabulous profits.